Method for treating demyelinating disease
US10413559B2 · kind B2 · utility
1Cited by
3References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 28, 2014 |
| Grant date | Sep 17, 2019 |
| Priority date | — |
| Expiry date | Jan 28, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
It is an object of the present invention to provide a novel therapeutic agent for demyelinating disease which has an action to suppress demyelination of nerve axons. According to the present invention, a therapeutic agent for demyelinating disease which comprises cyclic phosphatidic acids, carba-cyclic phosphatidic acids, thia-cyclic phosphatidic acids, or a salt thereof is provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.